幼年皮肌炎从儿童期至成年期的疾病活动度轨迹
该回顾性纵向起始队列纳入172例特发性炎症性肌病(主要为幼年皮肌炎)患者,分析4725次就诊(1471患者年),识别出三个疾病活动度轨迹潜类别,基线DASm及基线至3个月或6个月的DASm变化可预测轨迹分组,早期高疾病活动度和治疗抵抗预测更慢性的长期病程。
要点
- 识别出三个疾病活动度轨迹潜类别:持续高活动度(10%)、中度活动度(34%)、早期高活动度但治疗反应好且长期低活动度(56%)。
- 基线DASm及基线至3个月或6个月的DASm变化(早期治疗反应)可预测轨迹分组。
- 早期高疾病活动度及最初数月治疗抵抗预测幼年皮肌炎更慢性的纵向病程。
核心结论
- 早期高疾病活动度及最初数月的治疗抵抗预测幼年皮肌炎更慢性的纵向病程。
研究设计与样本
- 回顾性纵向起始队列,纳入特发性炎症性肌病(主要为幼年皮肌炎)患者172例(64%为女性),诊断时中位年龄7.7岁,共分析4725次就诊(1471患者年)。
主要发现
- 以改良DAS(DASm)测量纵向疾病活动度,识别出三个潜类别,其轨迹由基线DASm及基线至3个月或基线至6个月的DASm变化(早期治疗反应)预测。
- 在纳入基线DASm及基线至6个月DASm变化为预测因子的分析中,类别1(10%)为持续高疾病活动度,类别2(34%)为中度疾病活动度,类别3(56%)为早期高疾病活动度但治疗反应好且长期低疾病活动度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess whether there are identifiable subgroups of disease activity trajectory in a population of JDM patients-followed throughout childhood and into adulthood-and determine factors that predict those trajectory groupings. METHODS: This is a retrospective, longitudinal inception cohort of patients with idiopathic inflammatory myopathies, largely JDM. We sought to identify baseline factors that predict membership into different groups (latent classes) of disease activity trajectory. RESULTS: A total of 172 patients (64% females), with median age at diagnosis of 7.7 years, were analysed. We studied 4725 visits (1471 patient-years). We identified three latent classes of longitudinal disease activity, as measured by the modified DAS (DASm), with distinct class trajectories predicted by DASm at baseline, and by the changes of DASm from either baseline to 3 months or baseline to 6 months (early response to therapy). In the analysis in which DASm at baseline and the changes of DASm from baseline to 6 months are included as predictors, Class 1 (10%) has persistently high disease activity, Class 2 (34%) is characterized by moderate disease activity and Class 3 (56%) is characterized by individuals with a high early disease activity but an apparently good response to treatment and long-term low disease activity. CONCLUSION: High early disease activity, and treatment resistance in the first few months, predict a more chronic longitudinal course of JDM.
引用
- Nozawa T, Pullenayegum EM, Bell-Peter A, et al. Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood. Rheumatology (Oxford). 2024. PMID: 38216715. doi:10.1093/rheumatology/keae027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。